![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/473 | (2006.01) |
A61K 9/4825 | (2013.01) | ||
A61P 37/00 | (2006.01) | ||
A61K 31/403 | (2013.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 17/10 | (2018.01) | ||
A61P 17/06 | (2018.01) | ||
A61P 37/02 | (2018.01) | ||
A61P 19/02 | (2018.01) | ||
A61P 3/10 | (2018.01) | ||
A61P 29/00 | (2018.01) | ||
A61P 35/00 | (2018.01) |
(11) | Patento numeris | 3242666 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16700936.4 |
Europos patento paraiškos padavimo data | 2016-01-06 | |
(97) | Europos patento paraiškos paskelbimo data | 2017-11-15 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2024-10-16 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/012289 |
Data | 2016-01-06 |
(87) | Numeris | WO 2016/112075 |
Data | 2016-07-14 |
(30) | Numeris | Data | Šalis |
201562100362 P | 2015-01-06 | US | |
201562159550 P | 2015-05-11 | US |
(72) |
GLICKLICH, Alan , US
KAM, Maria Matilde Sanchez , US
SHANAHAN, William R. , US
|
(73) |
Arena Pharmaceuticals, Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
(54) | COMPOUND FOR USE IN TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR |
COMPOUND FOR USE IN TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR |